OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2021
(4)
2019
(4)
2025
(3)
2024
(3)
2023
(2)
2020
(2)
2026
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Human parainfluenza virus evolution during lung infection of immunocompromised individuals promotes viral persistence.
Not available
S-EPMC8631596
|
biostudies-literature
Cite
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Not available
S-EPMC4927341
|
biostudies-literature
Cite
Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of <i>D</i>ual <i>A</i>nti-CTLA-4 and Anti-PD-1 blockade in <i>R</i>are <i>T</i>umors (DART) SWOG S1609 (Cohort 38).
Not available
S-EPMC12542749
|
biostudies-literature
Cite
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.
Not available
S-EPMC10133891
|
biostudies-literature
Cite
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101).
Not available
S-EPMC10854344
|
biostudies-literature
Cite
Tuberculosis following PD-1 blockade for cancer immunotherapy.
Not available
S-EPMC7372940
|
biostudies-literature
Cite
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
Not available
S-EPMC8330584
|
biostudies-literature
Cite
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Not available
S-EPMC8061836
|
biostudies-literature
Cite
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors.
Not available
S-EPMC11440191
|
biostudies-literature
Cite
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
Not available
S-EPMC10842092
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets